This application is for a """"""""Mentored Patient-Oriented Research Career Development Award"""""""" (K23) to study treatment adherence in co-occurring psychiatric and drug use disorders (COD), under the mentorship of Bruce J. Rounsaville, M.D. and Richard S. Schottenfeld, M.D. Nonadherence is a critical issue in COD, especially among those with depressive disorders, as it occurs frequently and limits the maximal benefit achieved by efficacious treatments, particularly those with the potential to improve both conditions (e.g., antidepressants). Therefore, adherence-enhancing interventions for COD can optimize the efficacy of treatments. They are also adaptable to new treatments that are being developed. While preliminary studies indicate that adherence-enhancing interventions are efficacious for patients with non-COD, little systematic evaluation has occurred in COD. Compared to developing new contents for treatment, studying brief strategies to improve adherence to existing treatments is a highly cost-efficient approach that can have a large and rapid payoff. The research plan for this K23 application entails: 1) the evaluation of adherence issues in 9 ongoing studies and 2) completion of a new clinical trial evaluating innovative adherence-enhancing methods for COD in a dual-diagnosis outpatient clinic. This new clinical trial will employ a dismantling design, within which 75 outpatients with co-occurring depressive disorders and drug abuse/dependence (CODDA) will be randomly assigned to: 1) Treatment-as-Usual (TAU), a control condition offering medication management, standard education regarding diagnosis and the importance of adherence, and group counseling, 2) TAU+Adherence Feedback (TAU+AF), in which patients receive TAU plus computerized feedback on medication and counseling adherence, based on Medication Event Monitoring System (MEMS; Aprex Corporation, Fremont, CA) data and attendance records, or 3) TAU+Motivationally Enhanced Feedback (TAU+MEF), in which TAU plus Motivational Enhancement Therapy and Contingency Management will be added to AF. Primary outcome measures are: 1) rates of adherence to antidepressant medication, as measured by MEMS caps and self-report, 2) rates of counseling attendance, and 3) reductions in illicit drug use, including achievement of abstinence, as assessed by twice-weekly urine toxicology tests and self-report. Secondary outcomes include reductions in depressive symptomatology and rates of re-hospitalization.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23DA015144-03
Application #
6805283
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Czechowicz, Dorynne D
Project Start
2002-09-25
Project End
2007-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
3
Fiscal Year
2004
Total Cost
$134,481
Indirect Cost
Name
Yale University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Pantalon, Michael V; Murphy, Mary K; Barry, Declan T et al. (2014) Predictors and moderators of aftercare appointment-keeping following brief motivational interviewing among patients with psychiatric disorders or dual diagnosis. J Dual Diagn 10:44-51
Pantalon, Michael V; Martino, Steve; Dziura, James et al. (2012) Development of a scale to measure practitioner adherence to a brief intervention in the emergency department. J Subst Abuse Treat 43:382-8
D'Onofrio, Gail; Pantalon, Michael V; Degutis, Linda C et al. (2008) Brief intervention for hazardous and harmful drinkers in the emergency department. Ann Emerg Med 51:742-750.e2
Fiellin, David A; Moore, Brent A; Sullivan, Lynn E et al. (2008) Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. Am J Addict 17:116-20
Pantalon, Michael V; Maciejewski, Paul K; Desai, Rani A et al. (2008) Excitement-seeking gambling in a nationally representative sample of recreational gamblers. J Gambl Stud 24:63-78
Barry, Declan T; Moore, Brent A; Pantalon, Michael V et al. (2007) Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. J Gen Intern Med 22:242-5
Martino, Steve; Haeseler, Frederick; Belitsky, Richard et al. (2007) Teaching brief motivational interviewing to Year three medical students. Med Educ 41:160-7
Sullivan, Lynn E; Barry, Declan; Moore, Brent A et al. (2006) A trial of integrated buprenorphine/naloxone and HIV clinical care. Clin Infect Dis 43 Suppl 4:S184-90
Fiellin, David A; Pantalon, Michael V; Chawarski, Marek C et al. (2006) Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med 355:365-74
D'Onofrio, Gail; Pantalon, Michael V; Degutis, Linda C et al. (2005) Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department. Acad Emerg Med 12:249-56

Showing the most recent 10 out of 12 publications